AMR policies and Implementation issues: Developed vs Developing Countries

Abstract

The advent of antimicrobials has helped both developing and developed countries in treating and controlling infectious diseases. This achievement is now under threat because of development of resistance by the microbes to the antimicrobials. Antimicrobial resistance (AMR) is a growing public health concern that requires immediate action across the world. Given the gravity of the AMR crisis, the endorsed a (GAP) on antimicrobial resistance in 2015, directing member countries to develop and implement AMR action plans aligning with global action plan. As there are differences in the epidemiological situations in the infectious diseases and human factors accelerating the development of AMR, it would be interesting to note the differences in the approaches and implementation issues of AMR between developed and developing countries. are in different stages of implementing the national action plans. To have a reflection of similarities and difference of NAP to contain AMR and the implementation issues of both developed and developing countries with that , the authors have reviewed various published documents, other sources of information highlighting these issues. This chapter discusses about the policies and approaches of AMR containment and implementation issues of both developing and developed countries from the viewpoints of perspective; implementation perspective; monitoring evaluation perspective.